Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Thorax logoLink to Thorax
. 2002 Jun;57(6):509–512. doi: 10.1136/thorax.57.6.509

Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma

H Kanazawa 1, S Shiraishi 1, K Hirata 1, J Yoshikawa 1
PMCID: PMC1746342  PMID: 12037225

Abstract

Background: The production of peroxynitrite, an extremely potent oxidant, is increased in inflammatory lung disease. It is therefore important to measure antioxidant activity against peroxynitrite in epithelial lining fluid to examine the physiological effects of peroxynitrite in the airways of patients with asthma. This study was designed to determine whether peroxynitrite inhibitory activity in induced sputum is correlated with clinical characteristics and airway inflammatory indices in asthmatic patients.

Methods: Inflammatory indices were measured in induced sputum from 25 patients with asthma and 12 normal control subjects. Peroxynitrite inhibitory activity was also measured by monitoring rhodamine formation in sputum samples.

Results: Peroxynitrite inhibitory activity in induced sputum was significantly lower in asthmatic patients (52.4 (24.5)%) than in normal control subjects (92.1 (3.9)%, p<0.0001). Its activity was significantly correlated with forced expiratory volume in 1 second (FEV1) % predicted (r=0.774, p<0.0001) and bronchial hyperreactivity to methacholine (r=0.464, p=0.023). There was a significant negative correlation between peroxynitrite inhibitory activity and the degree of eosinophilic airway inflammation (% eosinophils, r=–0.758, p<0.0001; eosinophil cationic protein, r=–0.780, p<0.0001).

Conclusions: Decreased peroxynitrite inhibitory activity occurs in induced sputum of asthmatic patients. Since even in patients with stable asthma the airway lining fluid lacks peroxynitrite inhibitory activity, large amounts of peroxynitrite, which are further increased during an acute asthma attack, would not be completely inactivated and asthmatic airways might have markedly increased susceptibility to peroxynitrite induced airway injury.

Full Text

The Full Text of this article is available as a PDF (170.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. NO or no NO in asthma? Thorax. 1996 Feb;51(2):218–220. doi: 10.1136/thx.51.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Calhoun W. J., Reed H. E., Moest D. R., Stevens C. A. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):317–325. doi: 10.1164/ajrccm/145.2_Pt_1.317. [DOI] [PubMed] [Google Scholar]
  5. Cantin A. M., Fells G. A., Hubbard R. C., Crystal R. G. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest. 1990 Sep;86(3):962–971. doi: 10.1172/JCI114798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crow J. P., Beckman J. S., McCord J. M. Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry. 1995 Mar 21;34(11):3544–3552. doi: 10.1021/bi00011a008. [DOI] [PubMed] [Google Scholar]
  7. Crow J. P., Beckman J. S. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol. 1995;34:17–43. doi: 10.1016/s1054-3589(08)61079-0. [DOI] [PubMed] [Google Scholar]
  8. Ichinose M., Sugiura H., Yamagata S., Koarai A., Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):701–706. doi: 10.1164/ajrccm.162.2.9908132. [DOI] [PubMed] [Google Scholar]
  9. Kanazawa H., Hirata K., Yoshikawa J. Administration of SIN-1 induces guinea pig airway hyperresponsiveness through inactivation of airway neutral endopeptidase. Int Arch Allergy Immunol. 1999 Dec;120(4):317–322. doi: 10.1159/000024285. [DOI] [PubMed] [Google Scholar]
  10. Kanazawa H., Hirata K., Yoshikawa J. Possible mechanism of bronchoprotection by SIN-1 in anaesthetized guinea pigs: roles of nitric oxide and peroxynitrite. Clin Exp Allergy. 2000 Mar;30(3):445–450. doi: 10.1046/j.1365-2222.2000.00715.x. [DOI] [PubMed] [Google Scholar]
  11. Kanazawa H., Shiraishi S., Okamoto T., Hirata K., Yoshikawa J. Inhibition of bronchoprotective effects of beta2-adrenoceptor agonists by peroxynitrite in guinea pig airways. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1272–1276. doi: 10.1164/ajrccm.159.4.9808009. [DOI] [PubMed] [Google Scholar]
  12. Kanazawa H., Shoji S., Yamada M., Fujii T., Kawaguchi T., Kudoh S., Hirata K., Yoshikawa J. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma. J Allergy Clin Immunol. 1997 May;99(5):624–629. doi: 10.1016/s0091-6749(97)70024-1. [DOI] [PubMed] [Google Scholar]
  13. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):530–534. doi: 10.1164/ajrccm.153.2.8564092. [DOI] [PubMed] [Google Scholar]
  14. Kharitonov S. A., Yates D., Robbins R. A., Logan-Sinclair R., Shinebourne E. A., Barnes P. J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994 Jan 15;343(8890):133–135. doi: 10.1016/s0140-6736(94)90931-8. [DOI] [PubMed] [Google Scholar]
  15. Kooy N. W., Royall J. A., Ye Y. Z., Kelly D. R., Beckman J. S. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995 Apr;151(4):1250–1254. doi: 10.1164/ajrccm/151.4.1250. [DOI] [PubMed] [Google Scholar]
  16. Sadeghi-Hashjin G., Folkerts G., Henricks P. A., Verheyen A. K., van der Linde H. J., van Ark I., Coene A., Nijkamp F. P. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med. 1996 May;153(5):1697–1701. doi: 10.1164/ajrccm.153.5.8630623. [DOI] [PubMed] [Google Scholar]
  17. Saleh D., Ernst P., Lim S., Barnes P. J., Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998 Aug;12(11):929–937. [PubMed] [Google Scholar]
  18. Smith L. J., Houston M., Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1461–1464. doi: 10.1164/ajrccm/147.6_Pt_1.1461. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES